Martine Rothblatt, United Therapeutics CEO, sells $4.3M in shares
At a glance
- $UTHR today−0.65%last $562.02
- 52-week range8.5% below high$445.81 – $614.23
- In the headline$4.3 millionAmount
- Coverage4 this week9 in 30 days · 1.9× its usual pace
- Sector scannerCalmHealth Care
What it means
- What to watch: This one turns on a concrete figure ($4); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $UTHR -0.65% in the latest session.
- Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.
Where the stock stands
$UTHR last changed hands at $562.02, -0.65% on the session, 8.5% below its 52-week high of $614.23 and 26% above its low of $445.81 — a little above the middle of the range. Over the year it has ranged 38% from low to high: a moderate band — lively, not wild. These are latest-session quotes, not live prices — the live tape is on the $UTHR page.
How much coverage it is getting
Wook has logged 9 stories on $UTHR in the last 30 days, 4 of them this week. At its 30-day pace you would expect about 2 a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 9 neutral and 0 bearish. This one reads neutral, so it sits squarely with the crowd. 7 of the 9 (78%) came from Investing.com itself, so the count says as much about how often Investing.com hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, timing is everything. Trial results, FDA rulings, and pricing shifts can send stocks soaring or sinking in a heartbeat. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
The $UTHR page has all the details — charts, filings, and models. Compare sources to see if the story is confirmed or just echoed. Wook AI can help crunch the numbers and track the coverage.
Discussion
No one has weighed in yet. Start the discussion on this story.